Lilly Cares Oncology offers the following medications to eligible patients:

Name Prescribing Information Patient Prescribing Information
Alimta® (pemetrexed for injection)

Prescribing Information

Prescribing Patient Information

Cyramza® (ramucirumab) injection

Prescribing Information

 
Erbitux® (cetuximab) injection

Prescribing Information

 
Gemzar® (gemcitabine for injection)

Prescribing Information

 
Lartruvo™ (olaratumab) injection

Prescribing Information

 
Portrazza® (necitumumab) injection

Prescribing Information

 


Please see full prescribing information including Boxed Warning for Cyramza, Erbitux, and Portrazza.
Alimta®, Cyramza®, Erbitux®, Gemzar®, and Portrazza® are registered trademarks and Lartruvo is a trademark owned or licensed by Eli Lilly and Company, its subsidiaries or affiliates.